Ahhh, the dreamer strikes again. You really believe KK Fudd

New Post Public Reply Private Reply Replies (0) Message Board
hedge_fun Coat Tail Rider #2901
Ahhh, the dreamer strikes again. You really believe KK Fudd can show the posts were false and then prove damages? And you really think Fudd's co-conspirators are going to take the stand and explain to Judge Stephens why they haven't bought back and drove the share price up? I would certainly love to see that.

Quote:
Volentine will lose


Wasn't the mantra that he already lost and they just had to decide the damages? That's what has been posted repeatedly and that's what SFRX even claims in their SEC filings.

On or about October 15, 2014, the Company and Volentine entered into a stipulation whereby Volentine admitted to his tortious conduct, however the stipulated damages agreed to were rejected by the Court, and the Company is proceeding to trial on damages against Volentine in a non-jury trial on December 1, 2015.

See the bottom of page 22 here; https://www.sec.gov/Archives/edgar/data/11062...-16959.htm

But this is what Judge Stephens explained to "not my first rodeo Huffman" and Fudd in April.

THE COURT: Once again, though, if you prove it's

8 all false,
if you prove that the guy -- even if you

9 were able to prove that the guy just sits around and

10 makes stuff up for sport --

11 MR. HUFFMAN: Right.

12 THE COURT: -- if you're able to do that , what's

13 the -- how do you get past the next couple of links

14 that you need in your chain; that is, how do you show

15 it caused any damages and how do you show that
--


16 MR. HUFFMAN: Well that's for the finder of fact,

17 in deed, to make that nexus. But we show the postings

18 and you can show that --

19 THE COURT: Well isn't that me ?

20 MR. HUFFMAN: It is.

21 THE COURT: Yeah.

22 MR. HUFFMAN: But we show the -- Judge, I believe

23 the evidence is there. This isn't my first rodeo.

24 THE COURT: Well I'm asking you so let's hear it.

25 MR. HUFFMAN: Okay. So he makes a posting on a

1 Tuesday -- all right? -- or a number of postings,

2 saying that there's insider trading, they're stealing

3 treasure. Because this is a treasure recovery company

4 that's out there on the east coast. Okay?

5 THE COURT: I thought he was saying that there

6 isn't any treasure.


7 MR. HUFFMAN: Exactly. Right. Or he says there

8 isn't any treasure or they're stealing it, or they're

9 giving these fraudulent and security ... and then the

10 next day there's a massive sale. Okay?

11 Or have people available who can come in and

12 testify that would have put money into the company

13 directly, but they read his postings and they did not.

14 We also have people available who said they read

15 his postings. They were shareholders of they company.

16 They sold, thus driving down the price because they

17 sold.

18 THE COURT: But when they found out it was false,

19 did they buy it back and drive the price back up?


20 MR. HUFFMAN: Well, Judge that's not really --

21 THE COURT: No, it is. You've got to understand.

22 You can't show a temporary change in price which --

23 you know, if the price goes down tomorrow because of

24 something that somebody said that was false, the rest

25 of the world realizes it's true the day after

1 tomorrow, the price goes back up, then you don't have

2 any damages --


3 MR. HUFFMAN: Judge, I --

4 THE COURT: -- if that what happens.

5 MR. HUFFMAN: I understand the theory. However,

6 this was an ongoing -- our original lawsuit is an

7 ongoing period of time -- I believe covered a period

8 of six months -- that could show the diminution in the

9 value of the value of the stock price.

10 That continued. Okay? Even during the time of

11 his violation of the order -- okay? -- there was

12 reactions in the market -- okay? -- because of his

13 postings.

14 THE COURT: What I'm trying to tell you is --

15 MR. HUFFMAN: I can also argue res ipsa loquitur.

16 THE COURT: No, you can't. There is -- there is a

17 bunch of people out there -- I used to be one -- who

18 used scientific method to try to evaluate the changes

19 in stock prices as a result of the release of

20 certain kinds of information --

21 MR. HUFFMAN: Right.

22 THE COURT: -- true or false information -- into

23 the marketplace.

24 And there are accepted scientific methods for

25 being able to determine the difference between

1 information release and randomness or temporary blimps

2 based on information being false that everybody pretty

3 quickly figures out is false.


4 MR. HUFFMAN: Right.

5 THE COURT: All the stuff that you showed me in

6 the Complaint originally -- in the original Complaint

7 -- I realize you're talking about different stuff

8 now, but the stuff that was in the Complaint was the

9 kind of information, which if it was false, would

10 usually be found out by the rest of the market to be

11 false and any sort of damage to the stock price that

12 came from that bad information would be -- would be

13 likely to be recovered.


14 MR. HUFFMAN: I would have to disagree with the

15 Court that --

16 THE COURT: Well you might want to read the book I

17 wrote on the subject.


18 MR. HUFFMAN: I will do so.


Now here's the funny part of your post where you really dream big.

Quote:
then you will lose.


Huffman told me that well over a year ago, and Cliff Hunt threatened me earlier this year. All I had to do was make just one more post.......JUST ONE MORE. Of course they were also investigating to see if my post made the stock price drop. Plus some shareholders were going to sue me if I didn't respond properly to Hunt's threat.

Well.......keep dreaming dreamer. But if you all decide to make a move I look forward to meeting you in court. You all can explain to the Judge what's false, the damages caused, and why the market didn't react favorably when it figured out my post were false.

I mean how many times have you posted that I'm wrong?

Quote:
Wrong again,


GL dreamer.







Seafarer Exploration (SFRX) Stock Research Links

SFRX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading